Antioxidant status after iloprost treatment in patients with Raynaud’s phenomenon secondary to systemic sclerosis

By Balbir-Gurman Alexandra   Braun-Moscovici Yolanda   Livshitz Vladimir   Schapira Daniel   Markovits Doron   Rozin Alexander   Boikaner Tatiana   Nahir A.  

Clinical Rheumatology, Vol. 26, Iss. 9, 2007-09 ,pp. : 1517-1521

Springer Publishing Company

Access to resources Recommend Favorite

Laser Doppler Imaging—A New Technique for Quantifying Microcirculatory Flow in Patients with Primary Raynaud's Phenomenon and Systemic Sclerosis

By Clark S.   Campbell F.   Moore T.   Jayson M.I.V.   King T.A.   Herrick A.L.  

Microvascular Research, Vol. 57, Iss. 3, 1999-05 ,pp. : 284-291

Academic Press

Access to resources Recommend Favorite

The usefulness of power Doppler ultrasonography in differentiating primary and secondary Raynaud’s phenomenon

By Lee Sang   Lee Sang   Yoo Wan  

Clinical Rheumatology, Vol. 25, Iss. 6, 2006-11 ,pp. : 814-818

Springer Publishing Company

Access to resources Recommend Favorite

Clinical diagnosis found in patients with Raynaud's phenomenon: a multicentre study

By Grassi W.   De Angelis R.   Lapadula G.   Leardini G.   Scarpa R.  

Rheumatology International, Vol. 18, Iss. 1, 1998-06 ,pp. : 17-20

Springer Publishing Company

Access to resources Recommend Favorite

Endothelin-1 and Cold Provocation in Health, Primary Raynaud's Phenomenon, and Progressive Systemic Sclerosis

By Dorffler-Melly J.   Luscher T.F.   Wenk M.   Wen S.   Bollinger A.   Franzeck U.K.  

Microvascular Research, Vol. 52, Iss. 2, 1996-09 ,pp. : 193-197

Academic Press

Access to resources Recommend Favorite